Billionaire Singer threatens to sue AbbVie over Shire breakup

Carly Helfand

A $ 1.64 billion fee may have placated buyout target after  pulled the plug on their $ 55 billion agreement. But investors? At least one may still be planning a little ax-grinding.


FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS